HempMeds: A Leader in Emerging CBD Market


Ryan Allway

October 3rd, 2017

Exclusive, News, Top News


The market for hemp-based cannabidiol (“CBD”) is projected to exceed $1 billion in just three years, according to Brightfield Group, which would mean a 55% compound annual growth rate. Unlike medical marijuana, hemp-based CBDs contain less than 0.3% tetrahydrocannabinol (“THC”) and is non-psychoactive. This means that hemp-based CBDs can be legally sold across all 50 states and in many countries around the world.

Medical Marijuana Inc.’s (OTC Pink: MJNA) HempMeds subsidiary sells hemp-based CBD oil under the Real Scientific Hemp Oil™ – or RSHO™ – brand both domestically and internationally. According to the Brightfield Group, RSHO is one of the top five online brands in the United States alongside CW Hemp, PlusCBD Oil, Elixinol, and CannazALL. The brand has also gained strong traction in foreign markets like Mexico, Brazil, and Puerto Rico.

A Fragmented Market

The market for hemp-based CBD oils is highly fragmented with several small competitors rather than a single market leader. Since cannabinoids are heavily regulated on federal level, many large companies are hesitant to enter the market. The upshot is that investors have a unique opportunity to purchase pure-play opportunities in the industry as they ramp up production and become leaders in the burgeoning industry.

Consumer interest in hemp oil has been on the rise in recent years, according to data from Google Trends. With medical and recreational cannabis legalization across many states, consumers are becoming increasingly aware of the potential benefits that cannabinoids offer when treating various ailments. Researchers have also had an easier time studying the beneficial effects of cannabinoids with a growing number of papers published.

What is RSHO™?

HempMeds RSHO™ is a full spectrum, complete CBD hemp oil that contains the highest quality hemp oil in the industry with 10% to 30% CBD content. The RSHO™ Blue Label is the most popular version of the brand that goes through a decarboxylation process. RSHO™ Gold Label goes through an additional filtration process to create a great taste and smooth consistency. And, RHSO™ Green Label is a raw form that is as close as you can get to juicing a hemp plant.

The company also provides RSHO™ CBD Capsules that provide all of the benefits of CBD oil in a convenient vegan capsule that fits perfectly into a morning routine; RSHO™ CBD Liquid contains a combination of hemp oil and coconut-derived MCT oil; RSHO™ Tinctures that provide greater concentrations than the CBD Liquid product; and, RSHO™ CBD Salve that helps soothe rough elbows, heels, and cuticles.

Looking Ahead

Medical Marijuana Inc. (OTC Pink: MJNA) has made tremendous progress in advancing these products. In 2012, RSHO™ became the first-ever mainstream CBD oil in production that was legal in over 50 states and 40 countries. In 2014, it became the first ever legal CBD oil in Brazil, where it is now subsidized by the government and covered by health insurance. And in 2016, RSHO-X™ THC-free CBD oil became the first ever legal CBD oil in Mexico.

Management is focused on consolidating its leadership position in the hemp oil space by continuing to focus on domestic sales and international expansion. By working with researchers, the company hopes to continue expanding access to CBD oil to patients in need. The company’s direct-to-consumer and sales ambassador marketing approaches could also help its supplements reach a much wider consumer demographic over time.

For more information, visit the company’s website at www.hempmedspx.com or www.medicalmarijuanainc.com.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

Ryan Allway

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading